Michael L. Cibull

1.4k total citations
34 papers, 1.0k citations indexed

About

Michael L. Cibull is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Michael L. Cibull has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Pathology and Forensic Medicine and 8 papers in Surgery. Recurrent topics in Michael L. Cibull's work include Breast Lesions and Carcinomas (8 papers), Breast Cancer Treatment Studies (7 papers) and Endometrial and Cervical Cancer Treatments (5 papers). Michael L. Cibull is often cited by papers focused on Breast Lesions and Carcinomas (8 papers), Breast Cancer Treatment Studies (7 papers) and Endometrial and Cervical Cancer Treatments (5 papers). Michael L. Cibull collaborates with scholars based in United States and United Kingdom. Michael L. Cibull's co-authors include Jerome S. Burke, Ronald F. Dorfman, Richard T. Hoppe, Betsy F. Fink, Xiangdong Cui, Dayong Gao, Lee L.Q. Pu, Changguo Chen, Lu‐Zhe Sun and Abhik Bandyopadhyay and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Michael L. Cibull

32 papers receiving 956 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael L. Cibull United States 16 306 255 241 233 164 34 1.0k
Anisa Kanbour United States 19 112 0.4× 251 1.0× 217 0.9× 219 0.9× 80 0.5× 44 942
Daisy M. D. S. Sie‐Go Netherlands 19 107 0.3× 257 1.0× 298 1.2× 242 1.0× 76 0.5× 33 1.0k
Jaclyn C. Watkins United States 15 306 1.0× 234 0.9× 254 1.1× 453 1.9× 235 1.4× 46 1.2k
M. Ruhul Quddus United States 19 131 0.4× 170 0.7× 372 1.5× 269 1.2× 157 1.0× 102 1.1k
Sadok Korbi Tunisia 20 295 1.0× 251 1.0× 67 0.3× 439 1.9× 181 1.1× 97 1.2k
Nader Husseinzadeh United States 18 61 0.2× 256 1.0× 312 1.3× 296 1.3× 122 0.7× 48 1.2k
Elvio G. Silva United States 25 183 0.6× 508 2.0× 711 3.0× 619 2.7× 58 0.4× 33 1.6k
David Millan United Kingdom 18 93 0.3× 184 0.7× 328 1.4× 170 0.7× 160 1.0× 41 996
Andrea Palicelli Italy 14 123 0.4× 185 0.7× 121 0.5× 238 1.0× 61 0.4× 112 732

Countries citing papers authored by Michael L. Cibull

Since Specialization
Citations

This map shows the geographic impact of Michael L. Cibull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael L. Cibull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael L. Cibull more than expected).

Fields of papers citing papers by Michael L. Cibull

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael L. Cibull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael L. Cibull. The network helps show where Michael L. Cibull may publish in the future.

Co-authorship network of co-authors of Michael L. Cibull

This figure shows the co-authorship network connecting the top 25 collaborators of Michael L. Cibull. A scholar is included among the top collaborators of Michael L. Cibull based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael L. Cibull. Michael L. Cibull is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Huh, Warner K., Michael L. Cibull, Holly H. Gallion, et al.. (2011). Consistency of In Vitro Chemoresponse Assay Results and Population Clinical Response Rates Among Women With Endometrial Carcinoma. International Journal of Gynecological Cancer. 21(3). 494–499. 7 indexed citations
4.
Martin, Jeremiah T., et al.. (2011). Infection of an esophageal cyst following endoscopic fine-needle aspiration. International Journal of Surgery Case Reports. 2(6). 144–146.
5.
Tewari, Krishnansu S., Virginia L. Filiaci, Nick M. Spirtos, et al.. (2011). Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: A Gynecologic Oncology Group study. Gynecologic Oncology. 125(1). 87–93. 16 indexed citations
6.
Cibull, Michael L., Terry D. Stratton, Luis Samayoa, et al.. (2010). Should Histologic Grade Be Incorporated into the TNM Classification System for Small (T1, T2) Node-Negative Breast Adenocarcinomas?. Pathology Research International. 2011. 1–4. 5 indexed citations
7.
Davis, Joseph T., Michael L. Cibull, Patrick C. McGrath, et al.. (2007). Size of Sentinel Node Tumor Deposits and Extent of Axillary Lymph Node Involvement: Which Breast Cancer Patients May Benefit From Less Aggressive Axillary Dissections?. Annals of Surgical Oncology. 14(8). 2221–2227. 7 indexed citations
8.
Rinker, Brian, Xiangdong Cui, Dayong Gao, et al.. (2007). Cryopreservation of Composite Tissue Transplants. Hand. 3(1). 17–23. 13 indexed citations
9.
Davis, Joseph T., Michael L. Cibull, Patrick C. McGrath, et al.. (2006). Ultrasound-Guided Fine-Needle Aspiration of Clinically Negative Lymph Nodes Versus Sentinel Node Mapping in Patients at High Risk for Axillary Metastasis. Annals of Surgical Oncology. 13(12). 1545–1552. 46 indexed citations
10.
Davis, Joseph T., et al.. (2005). Sentinel node micrometastasis in breast carcinoma may not be an indication for complete axillary dissection. Modern Pathology. 18(6). 762–768. 40 indexed citations
11.
12.
Gallion, Holly H., Virginia L. Brunetto, Michael L. Cibull, et al.. (2003). Randomized Phase III Trial of Standard Timed Doxorubicin Plus Cisplatin Versus Circadian Timed Doxorubicin Plus Cisplatin in Stage III and IV or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study. Journal of Clinical Oncology. 21(20). 3808–3813. 76 indexed citations
13.
Schilder, Jeanne M., Amy Thompson, Paul D. DePriest, et al.. (2002). Outcome of Reproductive Age Women with Stage IA or IC Invasive Epithelial Ovarian Cancer Treated with Fertility-Sparing Therapy. Gynecologic Oncology. 87(1). 1–7. 179 indexed citations
14.
Cibull, Michael L.. (1999). Handling Sentinel Lymph Node Biopsy Specimens. Archives of Pathology & Laboratory Medicine. 123(7). 620–621. 10 indexed citations
15.
Bandyopadhyay, Abhik, Yong Zhu, Michael L. Cibull, et al.. (1999). A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells.. PubMed. 59(19). 5041–6. 96 indexed citations
16.
Spires, Susan E., et al.. (1995). Etiologies for Non-Correlating Cervical Cytologies and Biopsies. American Journal of Clinical Pathology. 103(5). 594–597. 55 indexed citations
17.
Boucher, Leslie D., Makoto Aoki, Eun Y. Lee, & Michael L. Cibull. (1994). Malakoplakia of Liver Associated with a Perforated Colonic Diverticulum. Journal of Clinical Gastroenterology. 19(4). 318–320. 5 indexed citations
18.
Spires, Susan E., C. Darrell Jennings, Evelyn R. Banks, et al.. (1994). Proliferating cell nuclear antigen in prostatic adenocarcinoma: Correlation with established prognostic indicators. Urology. 43(5). 660–666. 16 indexed citations
19.
Damm, Douglas D, et al.. (1993). Investigation into the histogenesis of congenital epulis of the newborn. Oral Surgery Oral Medicine Oral Pathology. 76(2). 205–212. 66 indexed citations
20.
Cibull, Michael L., et al.. (1978). Immunoblastic lymphadenopathy and adenocarcinoma of the pancreas.A case report. Cancer. 42(4). 1883–1885. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anisa Kanbour Breakdown of academic impact, for papers by Daisy M. D. S. Sie‐Go Breakdown of academic impact, for papers by Jaclyn C. Watkins Breakdown of academic impact, for papers by M. Ruhul Quddus Breakdown of academic impact, for papers by Sadok Korbi Breakdown of academic impact, for papers by Nader Husseinzadeh Breakdown of academic impact, for papers by Elvio G. Silva Breakdown of academic impact, for papers by David Millan Breakdown of academic impact, for papers by Andrea Palicelli
Rankless by CCL
2026